YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Biotidinase Deficiency Accompanied by Diffuse Demyelination and Cerebral Atrophy

dc.authorid Sal, Ertan/0000-0003-2761-2675
dc.authorscopusid 36180210800
dc.authorscopusid 59619525900
dc.authorscopusid 26030045000
dc.authorscopusid 7101974609
dc.authorscopusid 16834732700
dc.authorscopusid 26531767700
dc.authorwosid Temel, Hayrettin/Aaq-3801-2020
dc.authorwosid Sal, Ertan/Aak-1511-2021
dc.authorwosid Okur, Mesut/Aas-6957-2020
dc.contributor.author Okur, Mesut
dc.contributor.author Bektas, Mehmet Selcuk
dc.contributor.author Temel, Hayrettin
dc.contributor.author Caksen, Huseyin
dc.contributor.author Acikgoz, Mehmet
dc.contributor.author Sal, Ertan
dc.date.accessioned 2025-05-10T16:47:05Z
dc.date.available 2025-05-10T16:47:05Z
dc.date.issued 2012
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Okur, Mesut] Duzce Univ, Sch Med, Dept Pediat, TR-81620 Duzce, Turkey; [Bektas, Mehmet Selcuk; Temel, Hayrettin; Acikgoz, Mehmet; Sal, Ertan] Yuzuncu Yil Univ, Sch Med, Dept Pediat, Van, Turkey; [Caksen, Huseyin] Yuzuncu Yil Univ, Sch Med, Dept Pediat Neurol, Van, Turkey en_US
dc.description Sal, Ertan/0000-0003-2761-2675 en_US
dc.description.abstract Biotinidase deficiency is an inherited disorder which has autosomal recessive pattern; it occurs in approximately 1 in 60,000 live births. Usually it manifests seborrheic dermatitis, alopecia, ataxia, convulsions, hypotonia, developmental delay, hearing loss, chronic lactic acidosis and immune deficiency. Its diagnosis is made by the measurement of serum biotinidase enzyme activity and determination of the enzyme. Herein presented that a two and half-month-old boy with biotinidase enzyme deficiency which had cerebral atrophy without any skin signs. In the patients presented with refractory convulsions with unexplainable etiology without any skin lesions, as in our patient, biotinidase enzyme deficiency should be considered and the treatment should be established in early period to prevent many complications that may develop. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.doi 10.29333/ejgm/82461
dc.identifier.endpage 200 en_US
dc.identifier.issn 1304-3889
dc.identifier.issn 1304-3897
dc.identifier.issue 3 en_US
dc.identifier.scopus 2-s2.0-84872280167
dc.identifier.scopusquality N/A
dc.identifier.startpage 197 en_US
dc.identifier.uri https://doi.org/10.29333/ejgm/82461
dc.identifier.uri https://hdl.handle.net/20.500.14720/1341
dc.identifier.volume 9 en_US
dc.identifier.wos WOS:000421886800008
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Modestum Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Biotidinase Deficiency en_US
dc.subject Demyelination en_US
dc.subject Cerebral Atrophy en_US
dc.subject Child en_US
dc.title Biotidinase Deficiency Accompanied by Diffuse Demyelination and Cerebral Atrophy en_US
dc.type Article en_US

Files